SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-023580
Filing Date
2011-04-22
Accepted
2011-04-22 14:58:50
Documents
3
Period of Report
2011-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v219422_8k.htm 8-K 25415
2 v219422_ex10-1.htm EX-10.1 251308
3 v219422_ex10-2.htm EX-10.2 86555
  Complete submission text file 0001144204-11-023580.txt   364576
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 11775615
SIC: 4731 Arrangement of Transportation of Freight & Cargo